ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Specialist

Top Specialist Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GUSTAVO VILLARREAL M.D.

Specialist

9,713

$1.61M

513
423 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

43%
prescriptions for brand name drugs

Avg: 29%

$165
Average prescription price

Avg: $103

O HABAL

Specialist

9,244

$541K

208
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $103

DAMIEN SANDERLIN MD

Specialist

8,964

$726K

522
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

23%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $103

ELIAS BENHAMOU MD

Specialist

8,916

$503K

799
380 are 65+

40%
patients receiving schedule two controlled substances

Avg: 2%

68%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 29%

$56
Average prescription price

Avg: $103

HUMBERTO BRUSCHETTA MD, FACP

Specialist

8,900

$1.06M

439
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

48%
prescriptions for brand name drugs

Avg: 29%

$119
Average prescription price

Avg: $103

RONALD GLEASON M.D.

Specialist

8,693

$945K

447
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 29%

$109
Average prescription price

Avg: $103

JOSEPH BERGER D.O.

Specialist

8,581

$528K

317
235 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

15%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $103

DWAYNE WILLIAMS MD

Specialist

8,386

$520K

343
212 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

24%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $103

PEDRO HERNANDEZ M.D. P.A.

Specialist

8,171

$436K

500
456 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 29%

$53
Average prescription price

Avg: $103

JORGE DIAZ MD

Specialist

8,044

$758K

348
318 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

13%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 29%

$94
Average prescription price

Avg: $103

MARCEL LECHIN M.D.

Specialist

7,999

$781K

553
459 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

3%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 29%

$98
Average prescription price

Avg: $103

JOHN HARNEY MD

Specialist

7,955

$2.45M

422
194 are 65+

33%
patients receiving schedule two controlled substances

Avg: 2%

35%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 29%

$308
Average prescription price

Avg: $103

ROGER WILLETTE M.D.

Specialist

7,809

$515K

550
460 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 29%

$66
Average prescription price

Avg: $103

ALVIN PAYNE M.D.

Specialist

7,803

$428K

309
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $103

JONATHAN KLOCEK MD

Specialist

7,700

$478K

407
376 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

29%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $103

JEFFREY LEE MD

Specialist

7,608

$641K

410
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 29%

$84
Average prescription price

Avg: $103

CLAUDIA JORDAN M.D.

Specialist

7,358

$511K

311
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

28%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 29%

$69
Average prescription price

Avg: $103

CHRISTOPHER HAYS M.D.

Specialist

7,345

$464K

275
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

22%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $103

DIA ABOCHAMH MD

Specialist

7,339

$416K

574
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

4%
patients receiving schedule three controlled substances

Avg: 18%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 29%

$57
Average prescription price

Avg: $103

LOUIS ALPERN M.D.

Specialist

7,036

$844K

1730
1588 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

83%
prescriptions for brand name drugs

Avg: 29%

$120
Average prescription price

Avg: $103

JOSE SOTO MD

Specialist

7,036

$439K

596
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 29%

$62
Average prescription price

Avg: $103

AJAY SOBTI M.D.

Specialist

6,921

$468K

315
296 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 29%

$68
Average prescription price

Avg: $103

ARAVIND GANGASANI MD

Specialist

6,842

$377K

547
457 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 29%

$55
Average prescription price

Avg: $103

ATTIYA KHAN M.D.

Specialist

6,647

$420K

453
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $103

JORGE ONTIVEROS M.D.

Specialist

6,636

$315K

262
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

31%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $103

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank